Tea consumption and prostate cancer: an updated meta-analysis

Liping Xie(First Affiliated Hospital Zhejiang University), Xiangyi Zheng(Tianjin University), Zhenghui Hu(First Affiliated Hospital Zhejiang University), Xiao Wang(Qingdao University), Jie Qin(Shanghai Medical College of Fudan University), Qiqi Mao(First Affiliated Hospital Zhejiang University)
World Journal of Surgical Oncology
February 14, 2014
10.1186/1477-7819-12-38
Cited by 56

Related Papers

The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer
|Molecular Cancer|2020|383
Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis
|World Journal of Surgical Oncology|2019|276
Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels
|Oncotarget|2017|207
Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells <i>in vitro</i> and inhibits tumor growth <i>in vivo</i>
|Cancer Science|2009|188